| 12/13/2023 | BKGNIG | S&P lowers Pfizer
|
| 12/13/2023 | BKGNIG | Moody’s prunes Pfizer
|
| 11/1/2023 | BKBWEMGNIG | Pfizer revenues fall significantly; Covid products see sharp decline
|
| 10/17/2023 | GNIG | S&P changes Pfizer outlook to negative
|
| 5/19/2023 | IG | Market Commentary: Lighter IG issuance eyed as market digests week’s $62 billion of deals; ETF inflows up
|
| 5/17/2023 | EMIG | New Issue: Pfizer unit details $31 billion notes in eight tranches for Seagen acquisition
|
| 5/16/2023 | EMIG | New Issue: Pfizer unit prices $31 billion notes in eight tranches for Seagen acquisition
|
| 5/15/2023 | EMGNIG | S&P assigns Pfizer notes A+
|
| 5/15/2023 | EMGNIG | Moody’s rates Pfizer notes A1
|
| 5/15/2023 | EMIG | Pfizer unit to issue eight tranches of notes for Seagen acquisition
|
| 3/15/2023 | GNIG | Fitch changes Pfizer outlook to stable
|
| 3/13/2023 | GNIG | Moody’s revises Pfizer view to negative
|
| 3/13/2023 | BKBWGNIG | Pfizer expects unchanged IG ratings from $31 billion acquisition debt
|
| 11/21/2022 | GNIG | Moody's pumps up Pfizer
|
| 9/26/2022 | GNIG | Fitch changes Pfizer view
|
| 12/14/2021 | GNIG | Moody's alters Pfizer view to positive
|
| 10/14/2021 | GNIG | Fitch stabilizes Pfizer view
|
| 8/16/2021 | GNIG | New Issue: Pfizer sells $1 billion 1.75% 10-year notes at Treasuries plus 53 bps
|
| 8/16/2021 | BKGNIG | S&P rates Pfizer notes A+
|
| 8/16/2021 | BKGNIG | Moody's assigns A2 to Pfizer notes
|
| 8/16/2021 | GNIG | Pfizer to sell green senior notes due 2031 via four bookrunners
|
| 11/18/2020 | IGLM | Pfizer to fully redeem 5.8% notes due 2023, 1.95% notes due 2021
|
| 11/16/2020 | BKGNIG | S&P lowers Pfizer
|
| 11/16/2020 | BKGNIG | Moody’s downgrades Pfizer
|
| 6/15/2020 | BKIG | S&P rates Upjohn notes BBB-
|
| 6/15/2020 | IG | Upjohn expected to price about $12 billion of high-grade bonds to fund Mylan merger
|
| 5/22/2020 | IGLM | Pfizer, Wyeth recommend rejecting tender offer made by Huguenot
|
| 5/21/2020 | BKGNIG | Fitch rates Pfizer notes A
|
| 5/19/2020 | IG | New Issue: Pfizer details $4 billion of fixed-rate senior notes in four parts
|
| 5/18/2020 | IG | Market Commentary: Pfizer, Equinor, energy issuers tap primary; SSA supply on deck; credit spreads tighten
|
| 5/18/2020 | IG | New Issue: Pfizer prices $4 billion of fixed-rate senior notes in four tranches
|
| 5/18/2020 | BKGNIG | Moody's gives Pfizer notes A1
|
| 5/18/2020 | IG | Market Commentary: Morning Commentary: Pfizer, energy suppliers, ICE, RELX, Unum to tap high-grade primary
|
| 5/18/2020 | BKGNIG | S&P rates Pfizer notes AA-
|
| 5/18/2020 | IG | Pfizer to conduct offering of fixed-rate notes in four tranches
|
| 3/30/2020 | GNIG | Fitch rates Pfizer notes A
|
| 3/25/2020 | IG | Market Commentary: High-grade supply heavy; NIKE, McDonald’s, HSBC, Deere, 3M, Pfizer price; credit spreads firm
|
| 3/25/2020 | IG | S&P lowers Cabot ratings
|
| 3/25/2020 | IG | S&P lowers Cabot ratings
|
| 3/25/2020 | GNIG | New Issue: Pfizer sells $1.25 billion 2.625% 10-year notes at Treasuries plus 185 bps spread
|
| 3/25/2020 | BKGNIG | Moody's assigns Pfizer notes A1
|
| 3/25/2020 | IG | Market Commentary: Morning Commentary: Heavy high-grade supply on tap; NIKE, 3M, McDonald’s to price notes
|
| 3/25/2020 | BKGNIG | S&P rates Pfizer notes AA-
|
| 3/25/2020 | GNIG | Pfizer offers 10-year notes to fund eligible social impact projects
|
| 8/1/2019 | IG | Fitch lowers Pfizer
|
| 7/29/2019 | IG | Moody’s reviews Pfizer for downgrade
|
| 7/29/2019 | IG | S&P lowers Pfizer rating
|
| 6/17/2019 | IG | S&P puts Pfizer on watch
|
| 6/17/2019 | BKBWIG | Pfizer to use mostly debt, some cash to buy Array for $11.4 billion
|
| 3/8/2019 | IG | Market Commentary: Steady high-grade volume eyed; SoCal Edison holds calls; new issues mixed; CVS widens
|
| 3/8/2019 | IG | Market Commentary: Morning Commentary: SoCal Edison eyes market; Pfizer, Merck bonds mixed; inflows decline
|
| 3/5/2019 | IG | Market Commentary: Merck, Lloyds, Lazard, Japan Finance price $7.5 billion of bonds; Dell, Cimarex eye market
|
| 3/5/2019 | BKIGLM | Pfizer to refinance, redeem or buy back debt via $5 billion issue
|
| 3/5/2019 | IG | Market Commentary: Morning Commentary: Merck, Lazard, Lloyds, Japan Finance on tap; Dell, Cimarex eye market
|
| 3/5/2019 | IG | New Issue: Pfizer gives details on $5 billion of senior notes in five tranches
|
| 3/4/2019 | IG | Market Commentary: Investment-grade supply heavy; Pfizer, John Deere, MUFG, TD Bank, utilities among issuers
|
| 3/4/2019 | IG | New Issue: Pfizer prices $5 billion of senior notes in five tranches on tight side of talk
|
| 3/4/2019 | IG | Moody's rates Pfizer notes A1
|
| 3/4/2019 | IG | S&P rates Pfizer notes AA
|
| 3/4/2019 | IG | Market Commentary: Morning Commentary: Heavy supply from Pfizer, Leggett & Platt, Brown & Brown on tap
|
| 3/4/2019 | IG | Pfizer plans to conduct offering of fixed-rate notes in five parts
|
| 9/7/2018 | IG | Market Commentary: Carlyle prices; primary busiest since 2016; Cigna, Pfizer notes mixed; Nordea, Eni firm
|
| 9/7/2018 | IG | Market Commentary: Morning Commentary: High-grade market ends busiest week since 2016; outflows reported
|
| 9/6/2018 | IG | Market Commentary: Cigna prices $20 billion; CIBC sells notes; Carlyle, Mitsubishi UFJ eye deals; Pfizer mixed
|
| 9/6/2018 | IG | Market Commentary: Cigna prices $20 billion; CIBC sells notes; Carlyle, Mitsubishi UFJ eye deals; Pfizer mixed
|
| 9/6/2018 | IG | Market Commentary: Morning Commentary: CIBC offers notes; Cigna deal looms; Carlyle markets offering
|
| 9/5/2018 | IG | Fitch lifts CenterPoint Energy
|
| 9/5/2018 | IG | Fitch rates Pfizer notes A+
|
| 9/5/2018 | IG | Market Commentary: Morning Commentary: Mizuho, General Motors, EIB offer notes; Cigna, Carlyle eye deals
|
| 9/5/2018 | IG | New Issue: Pfizer gives details on $5 billion issue of senior notes in six parts
|
| 9/4/2018 | IG | Market Commentary: High-grade volume strong; Pfizer, MUFG, Unilever, Caterpillar, Bunge, Duke price notes
|
| 9/4/2018 | IG | New Issue: Pfizer prices $5 billion of senior notes in six tranches
|
| 9/4/2018 | IG | S&P gives AA to Pfizer notes
|
| 9/4/2018 | IG | Moody’s rates Pfizer notes A1
|
| 9/4/2018 | IG | Market Commentary: Morning Commentary: Pfizer, MUFG, Caterpillar, Duke Realty, Bunge on tap in primary
|
| 9/4/2018 | IG | Pfizer intends to sell fixed- and floating-rate notes in six parts
|
| 12/14/2017 | IGLM | Pfizer to issue 2.735% notes due 2043 in exchange; cash offer prices
|
| 12/8/2017 | IG | Fitch applies A+ to Pfizer notes
|
| 12/7/2017 | IG | S&P assigns AA to Pfizer notes
|
| 12/7/2017 | IG | Moody’s assigns A1 to Pfizer notes
|
| 12/7/2017 | IGLM | Pfizer holds exchange, cash offers for 6.5% notes due 2038, tender for 5.75% notes due 2021
|
| 7/18/2017 | IG | Fitch revises Pfizer to negative
|
| 3/1/2017 | IG | Fitch rates Pfizer notes A+
|
| 2/28/2017 | IG | S&P rates Pfizer notes AA
|
| 2/28/2017 | IG | Moody’s applies A1 to Pfizer notes
|
| 2/24/2017 | IG | Market Commentary: Fannie Mae, Pfizer sell notes; Bristol-Myers steady; Mizuho, Parker-Hannifin tighten
|
| 2/24/2017 | IG | New Issue: Pfizer prices $1.07 billion 30-year Taipei Exchange-listed notes at par to yield 4.2%
|
| 2/24/2017 | IG | Fitch rates Pfizer notes A+
|
| 2/24/2017 | IG | S&P rates Pfizer notes AA
|
| 2/24/2017 | IG | Moody’s applies A1 to Pfizer notes
|
| 2/24/2017 | IG | Market Commentary: Morning Commentary: Pfizer markets 30-year notes; Bristol-Myers improves in secondary market
|
| 2/24/2017 | IG | Pfizer to price 30-year Taipei Exchange-listed notes via bookrunners BNP and Deutsche Bank
|
| 12/22/2016 | IG | Market Commentary: BB&T prices $850 million floaters; bonds mixed; Anheuser-Busch firms; Duke Energy eases
|
| 12/22/2016 | IG | Market Commentary: Morning Commentary: BB&T to sell notes; Pfizer stronger; secondary market volume thins
|
| 11/21/2016 | IGLM | Pfizer holders tender $1.94 billion of 6.2% notes due 2019 in offer
|
| 11/18/2016 | IG | Market Commentary: Light volume forecast for holiday week; Abbott, Pfizer mixed; Chevron Phillips Chemical firms
|
| 11/18/2016 | IGLM | Pfizer prices tender offer for $3.25 billion of 6.2% notes due 2019
|
| 11/15/2016 | IG | Fitch rates Pfizer notes A+
|
| 11/15/2016 | IG | New Issue: Pfizer gives details on $6 billion five-part sale of fixed-rate notes
|
| 11/14/2016 | IG | Market Commentary: Pfizer, Morgan Stanley, Duke Energy Carolinas, American Water sell bonds; credit spreads ease
|
| 11/14/2016 | IG | New Issue: Pfizer prices $6 billion of fixed-rate notes in five tranches
|
| 11/14/2016 | IG | Moody’s applies A1 to Pfizer notes
|
| 11/14/2016 | IG | Market Commentary: Morning Commentary: Pfizer among issuers set to tap primary market; Consolidated Edison firms
|
| 11/14/2016 | IG | Pfizer plans to conduct offering of fixed-rate notes in five parts
|
| 11/14/2016 | IGLM | Pfizer begins tender for $3.25 billion of 6.2% senior notes due 2019
|
| 9/26/2016 | IG | Moody’s revises Pfizer to stable
|
| 6/2/2016 | IG | Market Commentary: Aetna, Citigroup, Brixmor, Nasdaq, RBC tap bond market; Mylan tightens; Pfizer mixed
|
| 6/2/2016 | IG | Market Commentary: Morning Commentary: Mylan notes tighten; Pfizer paper mixed; Libor yield rises 2 bps
|
| 6/1/2016 | IG | Fitch rates Pfizer notes A+
|
| 6/1/2016 | IG | New Issue: Pfizer details sale of $5 billion notes in five tranches
|
| 5/31/2016 | IG | Market Commentary: Mylan, Pfizer, JPMorgan, Norfolk, Southern California Gas price; Anheuser Busch firms
|
| 5/31/2016 | IG | New Issue: Pfizer prices $5 billion of notes in five tranches
|
| 5/31/2016 | IG | S&P applies AA to Pfizer notes
|
| 5/31/2016 | IG | Moody’s provides A1 to Pfizer notes
|
| 5/31/2016 | IG | Market Commentary: Morning Commentary: Pfizer, Norfolk to price; Walgreens stronger; credit spreads open tighter
|
| 5/31/2016 | IG | Pfizer intends to sell 2018, 2019, 2021 and 2026 notes, reissue 4.4% notes due 2044
|
| 5/16/2016 | IG | Moody’s changes Pfizer to negative
|
| 4/7/2016 | IG | Market Commentary: Standard Chartered prices tight; JPMorgan firms; Citi eases; Thermo tightens; Pfizer improves
|
| 4/6/2016 | IG | Market Commentary: KfW, Banque Federative, Swedish Export Credit do deals; Pfizer widens; Newell Rubbermaid firms
|
| 4/4/2016 | IG | Market Commentary: Primary sees $12 billion of issuance from Target, BMW, others; Pfizer, AT&T tighten modestly
|
| 1/12/2016 | IG | Market Commentary: Financials storm investment-grade primary; MetLife notes flat; Pfizer, AstraZeneca firm
|
| 12/3/2015 | IG | Market Commentary: BofA prices after delay, downgrade; ECB disappoints markets; Dollar General, Pfizer firm
|
| 11/25/2015 | IG | Market Commentary: High-grade primary expected to be busy in December; Pfizer, Burlington Northern tighten
|
| 11/24/2015 | IG | Fitch puts Pfizer on watch
|
| 11/24/2015 | IG | Market Commentary: Morning Commentary: Allergan tightens; Wells Fargo paper improves; credit spreads ease
|
| 11/23/2015 | IG | Market Commentary: Lloyds, HCP, MetLife do deals; Vodafone scraps 30-year bonds; Pfizer trades mostly flat
|
| 11/23/2015 | IG | S&P: Pfizer on negative watch with Allergan deal
|
| 11/23/2015 | IG | Moody’s affirms Pfizer
|
| 11/10/2015 | IG | New Issue: Zoetis details $1.25 billion sale of notes in five-, 10-year tranches
|
| 11/9/2015 | IG | Market Commentary: Chevron, ANZ, Delphi among onslaught of issuers; energy bonds mixed; credit spreads widen
|
| 11/9/2015 | IG | New Issue: Zoetis sells $1.25 billion of senior notes in five-, 10-year tranches
|
| 11/9/2015 | IG | Zoetis planning to offer senior notes in two maturities
|
| 10/2/2015 | IGLM | Pfizer wraps exchange for four series of Hospira notes after buyout
|
| 9/18/2015 | IGLM | Pfizer gives early tender update in exchange offers for Hospira notes
|
| 9/8/2015 | IG | Fitch assigns A+ to Pfizer notes
|
| 9/4/2015 | IG | S&P applies AA to Pfizer notes
|
| 9/4/2015 | IGLM | Pfizer begins exchange offers, consent solicitations for Hospira notes
|
| 2/5/2015 | IG | Market Commentary: Merck upsizes jumbo deal; Japan Finance, Costco price; Pfizer, Hospira active on acquisition
|
| 2/5/2015 | BKIG | Pfizer plans debt financing for $17 billion acquisition of Hospira
|
| 2/5/2015 | IG | Moody’s affirms Pfizer
|
| 7/29/2014 | IG | Market Commentary: Morning Commentary: High-grade bond spreads steady; eBay firms; Pfizer mostly unchanged
|
| 5/14/2014 | IG | Fitch rates Pfizer notes A+
|
| 5/13/2014 | IG | New Issue: Pfizer details $4.5 billion sale of notes in five tranches
|
| 5/12/2014 | IG | Market Commentary: Pfizer, Barclays among issuers to price about $13 billion of bonds; new paper mostly flat
|
| 5/12/2014 | IG | Market Commentary: Midday Commentary: Primary gears up for busy week; spreads tighter; Caterpillar Financial firms
|
| 5/12/2014 | IG | New Issue: Pfizer prices $4.5 billion of notes in five tranches due 2017-2044
|
| 5/12/2014 | IG | Pfizer plans four-part offering of notes
|
| 5/12/2014 | IG | S&P rates Pfizer notes AA
|
| 5/12/2014 | IG | Moody's assigns Pfizer notes A1
|
| 5/9/2014 | IG | Market Commentary: Midday Commentary: Spreads softer; financials mixed; Morgan Stanley eases; Pfizer firms
|
| 11/14/2013 | IGLM | Pfizer subsidiary to redeem all $1.75 billion of 5.5% notes due 2014
|
| 6/4/2013 | IG | Fitch rates Pfizer debt A+
|
| 5/29/2013 | IG | Market Commentary: Midday Commentary: Spreads in high-grade secondary market widen; new Pfizer notes weaker
|
| 5/29/2013 | IG | Market Commentary: Alexandria sells; GECC offers hybrid; secondary spreads widen during 'very volatile' session
|
| 5/28/2013 | IG | Market Commentary: Pfizer returns to market with $4 billion trade; Northrop, Agrium price; Pfizer notes firm
|
| 5/28/2013 | IG | New Issue: Pfizer taps market for $4 billion of notes in five tranches
|
| 5/28/2013 | IG | Pfizer eyes market for five-tranche note sale Tuesday
|
| 5/28/2013 | IG | Pfizer eyes market for multi-tranche note sale Tuesday
|
| 5/28/2013 | IG | S&P rates Pfizer notes AA
|
| 5/28/2013 | IG | Moody's rates Pfizer notes A1
|
| 11/5/2012 | IG | Market Commentary: AbbVie prices huge deal after delay; Boardwalk Pipelines, Invesco sell; secondary sees volume
|
| 8/28/2012 | IGLM | Pfizer lacks needed consents from holders of two Pharmacia note series
|
| 8/15/2012 | IGLM | Pfizer solicits consents to amend five series of Pharmacia debentures
|
| 8/13/2012 | IG | Pfizer to exchange some debt ahead of Zoetis initial public offering
|
| 5/30/2012 | IG | Market Commentary: Kraft does $6 billion monster deal, tightens in secondary; Charles Schwab sells preferreds
|
| 5/10/2012 | CVIGPF | Pfizer files automatic shelf registration for stock, preferreds, debt
|
| 4/23/2012 | IG | Moody's: Pfizer sale is negative
|
| 4/23/2012 | IG | Fitch: Pfizer unaffected
|
| 11/28/2011 | IG | Moody's rates Pfizer loan A1
|
| 9/23/2011 | IG | Fitch lowers Pfizer
|
| 7/7/2011 | IG | Moody's: Pfizer unchanged
|
| 10/12/2010 | IG | Fitch: Pfizer unaffected
|
| 10/4/2010 | IG | Fitch: Pfizer view to negative
|
| 2/4/2010 | IG | Market Commentary: Kraft, Berkshire, Pacific Life sell nearly $18 billion in bonds; Kraft tighter in trading
|
| 1/5/2010 | IG | Market Commentary: Foreigners Dexia, Barclays, Lloyds, KfW tap market, GE Capital lone domestic; spreads tighten
|
| 12/31/2009 | IG | Outlook 2010: Drug companies, money managers lead 2009's notable deals
|
| 12/24/2009 | IG | Market Commentary: New deals continue hiatus; financials active in trading, others quiet
|
| 10/30/2009 | IG | Pfizer announces successful consent solicitation for Wyeth notes
|
| 10/20/2009 | IG | Market Commentary: Citi sells FDIC notes, JPMorgan, Meccanica, KBN offer bonds; new JPMorgan active
|
| 10/20/2009 | IG | Market Commentary: Citi sells FDIC notes, JPMorgan, Meccanica, KBN offer bonds; new JPMorgan active
|
| 10/19/2009 | IG | Market Commentary: Southern, Temasek, Santander US Debt sell notes; secondary volume fades; investors eye EM
|
| 10/16/2009 | IG | Pfizer solicits consents to amend several series of Wyeth notes
|
| 10/16/2009 | IG | S&P lowers Pfizer, lifts Wyeth
|
| 10/16/2009 | IG | Moody's keeps Wyeth on review
|
| 10/16/2009 | IG | Market Commentary: B of A bonds widen; GE Capital unmoved on earnings; industrial trading null on bank focus
|
| 10/15/2009 | IG | Moody's lowers Pfizer, keeps Wyeth on review
|
| 10/15/2009 | IG | Fitch cuts Pfizer, ups Wyeth
|
| 7/24/2009 | IG | Market Commentary: Primary empties, coming week seen busier; Boeing, Bank of America unchanged, St. Jude gains
|
| 6/25/2009 | IG | Market Commentary: Citigroup, Jefferies, Analog Devices, MassMutual, Torchmark sell notes; Merck busy, up again
|
| 5/27/2009 | IG | S&P rates Pfizer notes AAA
|
| 5/27/2009 | IG | Moody's rates Pfizer's notes Aa2
|
| 5/26/2009 | IG | Fitch assigns Pfizer notes AA
|
| 4/13/2009 | IG | Market Commentary: Portland General Electric, California Water, Toll sell bonds; Portland General firms in trading
|
| 4/6/2009 | IG | Market Commentary: ConAgra, Hutchison Whampoa sell bonds; Suncorp-Metway, Ventas plan deals; secondary tightens
|
| 4/3/2009 | IG | Market Commentary: New Energy Transfer Partners bonds firm smartly, TJX still trading tight; primary activity seen muted
|
| 3/31/2009 | IG | Market Commentary: GE Capital prices $975 million FDIC deal; Ingersoll-Rand brings $655 million; spreads wider; Pfizer active
|
| 3/30/2009 | IG | Market Commentary: PNC brings $1 billion in FDIC-backed bonds; Ingersoll-Rand plans benchmark; spreads wider
|
| 3/27/2009 | IG | Market Commentary: Bank of New York Mellon, U.S. Bancorp, Morgan Stanley sell FDIC deals; B of A, Merrill widen
|
| 3/26/2009 | IG | Market Commentary: World Bank, Newell Rubbermaid, Sunoco, Berkshire Hathaway sell bonds; spread widen; John Deere gains
|
| 3/25/2009 | IG | Market Commentary: Wells Fargo, Lloyds TSB Bank, John Deere Capital, Idaho Power sell bonds; spreads tighter; Pfizer in demand
|
| 3/24/2009 | IG | Market Commentary: Bacardi, Verizon, Staples sells bonds as tone remains up; Time Warner Cable, Con Ed, Illinois Tool firm
|
| 3/23/2009 | IG | Market Commentary: Time Warner, Atmos, ConEd, Northwestern Energy, Praxair, Illinois Tool sells bonds; spreads tighten
|
| 3/20/2009 | IG | Market Commentary: Simon Property, Empire District Electric, Northwest Natural Gas price; Pfizer bonds popular
|
| 3/20/2009 | IG | Market Commentary: Simon Property, Empire District Electric, Northwest Natural Gas price; Pfizer bonds popular
|
| 3/19/2009 | IG | Market Commentary: UPS, Kansas City Power, Barrick Gold, Peco Energy price deals; spreads tighten, Shell bond widens
|
| 3/18/2009 | IG | Market Commentary: Shell, BHP Billiton, Duke Energy units, Marsh & McLennan sell bonds; Pfizer gains in secondary
|
| 3/17/2009 | IG | New Issue: Pfizer prices $13.5 billion of notes in five tranches
|
| 3/17/2009 | IG | Fitch gives Pfizer notes AA
|
| 3/17/2009 | IG | Market Commentary: Pfizer sells $13.5 billion bond issue; State Street, SoCal Edison price; Pfizer bonds tighten
|
| 3/16/2009 | IG | Pfizer to sell up to $10 billion of notes in five tranches, gives guidance: sources
|
| 3/16/2009 | IG | S&P rates Pfizer notes AAA
|
| 3/16/2009 | IG | Market Commentary: Pfizer plans mega deal; Progress Energy, Smith International sell bonds; financials tighten
|
| 3/11/2009 | IG | Moody's lowers Pfizer
|
| 1/26/2009 | IG | S&P: Pfizer on watch
|
| 1/26/2009 | IG | Moody's may cut Pfizer
|
| 1/26/2009 | IG | Fitch drops Pfizer
|
| 1/26/2009 | IG | Market Commentary: Primary's slow pace of issuance continues; Caterpillar, Pfizer bonds weaker, McDonald's better
|
| 12/19/2008 | IG | Fitch affirms Pfizer
|
| 9/2/2008 | IG | Market Commentary: KfW, AmEx Credit price notes, BB&T plans trust preferred issue; secondary tone slides late in day
|
| 4/21/2008 | IG | Moody's gives Pfizer loan Aa1
|
| 12/12/2007 | IG | Fitch drops Pfizer
|
| 12/7/2007 | IG | Moody's rates Pfizer notes Aa1
|
| 12/7/2007 | IG | S&P rates Pfizer notes AAA
|
| 12/7/2007 | IG | Fitch rates Pfizer notes AAA
|
| 10/19/2007 | IG | Moody's cuts Pfizer view to negative
|
